Dr. Jyothi Mallepalli
Claim this profileGSK Investigational Site
Studies Arthritis
Studies Rheumatoid Arthritis
5 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Jyothi Mallepalli is currently running
Baricitinib
for Rheumatoid Arthritis
This trial compares the safety of two treatments for rheumatoid arthritis, focusing on the risk of blood clots. One treatment is baricitinib, an oral medication used for moderate to severe cases.
Recruiting3 awards Phase 43 criteria
Deucravacitinib
for Sjögren's Syndrome
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Recruiting1 award Phase 3
More about Jyothi Mallepalli
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jyothi Mallepalli has experience with
- Baricitinib
- TNF Inhibitor
- Olokizumab
- Otilimab (GSK3196165)
- GSK3196165 (Otilimab)
- Tofacitinib
Breakdown of trials Jyothi Mallepalli has run
Arthritis
- Baricitinib for Rheumatoid Arthritis
- Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
Rheumatoid Arthritis
- Baricitinib for Rheumatoid Arthritis
- Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
Sjögren's Syndrome
Sjogren's Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jyothi Mallepalli specialize in?
Jyothi Mallepalli focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Jyothi Mallepalli currently recruiting for clinical trials?
Yes, Jyothi Mallepalli is currently recruiting for 2 clinical trials in Monroe Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Jyothi Mallepalli has studied deeply?
Yes, Jyothi Mallepalli has studied treatments such as Baricitinib, TNF Inhibitor, Olokizumab.
What is the best way to schedule an appointment with Jyothi Mallepalli?
Apply for one of the trials that Jyothi Mallepalli is conducting.
What is the office address of Jyothi Mallepalli?
The office of Jyothi Mallepalli is located at: GSK Investigational Site, Monroe, Louisiana 71203 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.